Articles with public access mandates - Crystal DenlingerLearn more
Not available anywhere: 2
Phase Ib study of Wnt inhibitor ipafricept with gemcitabine and nab-paclitaxel in patients with previously untreated stage IV pancreatic cancer
E Dotan, DB Cardin, HJ Lenz, W Messersmith, B O'Neil, SJ Cohen, ...
Clinical cancer research 26 (20), 5348-5357, 2020
Mandates: US National Institutes of Health
Deviations from standard chemoradiation among early-stage anal cancer patients
TM Churilla, L DeMora, E Handorf, NG Zaorsky, Y Dong, CS Denlinger, ...
International Journal of Radiation Oncology* Biology* Physics 100 (4), 945-949, 2018
Mandates: US National Institutes of Health
Available somewhere: 64
KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors
DS Hong, MG Fakih, JH Strickler, J Desai, GA Durm, GI Shapiro, ...
New England Journal of Medicine 383 (13), 1207-1217, 2020
Mandates: US National Institutes of Health, Damon Runyon Cancer Research Foundation …
American College of Sports Medicine roundtable report on physical activity, sedentary behavior, and cancer prevention and control
AV Patel, CM Friedenreich, SC Moore, SC Hayes, JK Silver, KL Campbell, ...
Medicine and science in sports and exercise 51 (11), 2391, 2019
Mandates: US National Institutes of Health
The challenges of colorectal cancer survivorship
CS Denlinger, AM Barsevick
Journal of the National Comprehensive Cancer Network 7 (8), 883-894, 2009
Mandates: US National Institutes of Health
Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised …
CS Fuchs, K Shitara, M Di Bartolomeo, S Lonardi, SE Al-Batran, ...
The Lancet Oncology 20 (3), 420-435, 2019
Mandates: German Research Foundation
Survivorship: introduction and definition
CS Denlinger, RW Carlson, M Are, KS Baker, E Davis, SB Edge, ...
Journal of the National Comprehensive Cancer Network 12 (1), 34-45, 2014
Mandates: US National Institutes of Health
Pancreas cancer‐associated weight loss
AE Hendifar, MQB Petzel, TA Zimmers, CS Denlinger, LM Matrisian, ...
The oncologist 24 (5), 691-701, 2019
Mandates: US National Institutes of Health, US Department of Veterans Affairs …
Weight management and physical activity throughout the cancer care continuum
W Demark‐Wahnefried, KH Schmitz, CM Alfano, JR Bail, PJ Goodwin, ...
CA: a cancer journal for clinicians 68 (1), 64-89, 2018
Mandates: US National Institutes of Health, US Department of Veterans Affairs …
Survivorship, version 2.2018, NCCN clinical practice guidelines in oncology
CS Denlinger, T Sanft, KS Baker, G Broderick, W Demark-Wahnefried, ...
Journal of the National Comprehensive Cancer Network 16 (10), 1216-1247, 2018
Mandates: US National Institutes of Health
Lifestyle factors in cancer survivorship: where we are and where we are headed
N Vijayvergia, CS Denlinger
Journal of personalized medicine 5 (3), 243-263, 2015
Mandates: US National Institutes of Health
Senior adult oncology
A Hurria, IS Browner, HJ Cohen, CS Denlinger, M DeShazo, M Extermann, ...
Journal of the National Comprehensive Cancer Network 10 (2), 162-209, 2012
Mandates: US National Institutes of Health
Survivorship in non–small cell lung cancer: challenges faced and steps forward
N Vijayvergia, PC Shah, CS Denlinger
Journal of the National Comprehensive Cancer Network 13 (9), 1151-1161, 2015
Mandates: US National Institutes of Health
Colorectal cancer survivorship: movement matters
CS Denlinger, PF Engstrom
Cancer Prevention Research 4 (4), 502-511, 2011
Mandates: US National Institutes of Health
Safety and efficacy of durvalumab and tremelimumab alone or in combination in patients with advanced gastric and gastroesophageal junction adenocarcinoma
RJ Kelly, J Lee, YJ Bang, K Almhanna, M Blum-Murphy, DVT Catenacci, ...
Clinical Cancer Research 26 (4), 846-854, 2020
Mandates: US National Institutes of Health
Pembrolizumab monotherapy in patients with previously treated metastatic high-grade neuroendocrine neoplasms: joint analysis of two prospective, non-randomised trials
N Vijayvergia, A Dasari, M Deng, S Litwin, T Al-Toubah, RK Alpaugh, ...
British journal of cancer 122 (9), 1309-1314, 2020
Mandates: US National Institutes of Health
Survivorship, version 2.2017, NCCN clinical practice guidelines in oncology
CS Denlinger, T Sanft, KS Baker, S Baxi, G Broderick, ...
Journal of the national comprehensive cancer network 15 (9), 1140-1163, 2017
Mandates: US National Institutes of Health
Perspectives of HER2-targeting in gastric and esophageal cancer
JN Gerson, S Skariah, CS Denlinger, I Astsaturov
Expert opinion on investigational drugs 26 (5), 531-540, 2017
Mandates: US National Institutes of Health
Effect of home-based exercise and weight loss programs on breast cancer–related lymphedema outcomes among overweight breast cancer survivors: The WISER Survivor randomized …
KH Schmitz, AB Troxel, LT Dean, A DeMichele, JC Brown, K Sturgeon, ...
JAMA oncology 5 (11), 1605-1613, 2019
Mandates: US National Institutes of Health
NCCN guidelines insights: survivorship, version 2.2020: featured updates to the NCCN guidelines
CS Denlinger, T Sanft, JJ Moslehi, L Overholser, S Armenian, KS Baker, ...
Journal of the National Comprehensive Cancer Network 18 (8), 1016-1023, 2020
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program